Smith-Whitley Kim

CIK 00018602971 companySOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001860297

Recent Transactions

20 trades

Disposition to Issuer
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-10-05−15,460→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-10-05−35,500→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-10-05−28,628→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-10-05−42,400→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-10-05−26,454→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-10-05−18,120→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Common Stock
2022-10-05−5,980→ 0 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2022-09-01+2,208→ 6,588 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-09-01−2,208→ 15,460 total
Tax Payment
Global Blood Therapeutics, Inc.
Common Stock
2022-09-01$68.15/sh−607→ 5,981 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-06-01−6,040→ 18,120 total
Tax Payment
Global Blood Therapeutics, Inc.
Common Stock
2022-06-01$24.02/sh−1,660→ 4,380 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2022-06-01+6,040→ 6,040 total
Award
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-03-01+17,668→ 17,668 total
Award
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-03-01+17,668→ 17,668 total
Award
Global Blood Therapeutics, Inc.
Stock Option (Right to buy)
2022-03-01+28,628→ 28,628 total
Award
Global Blood Therapeutics, Inc.
Restricted Stock Units
2021-06-01+24,160→ 24,160 total
Award
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2021-06-01+35,500→ 35,500 total
Award
Global Blood Therapeutics, Inc.
Restricted Stock Units
2021-06-01+6,300→ 6,300 total
Award
Global Blood Therapeutics, Inc.
Restricted Stock Units
2021-06-01+42,400→ 42,400 total

Companies

Global Blood Therapeutics, Inc.
See Remarks

Recent Filings

Address

C/O GLOBAL BLOOD THERAPEUTICS, INC. 181 OYSTER POINT BLVD.

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov